Referencias bibliográfícas
Alcalde, L. M. & Barsotti, S. (s. f.). Historic Agreement between U.S. and Cuba Pharmaceutical Companies. Kegler Brown Hill+Ritter. https://www.keglerbrown.com/case-studies/historic-agreement-between-u-s-and-cuba-pharmaceutical-companies/
Armstrong, D. (2024, 30 de abril). DTC Receives FDA SMP Letter for Phase 3 Clinical Trial of rhEGF. https://discothera.com/news/f/dtc-receives-fda-smp-letter-for-phase-3-clinical-trial-of-rhegf
Berlanga Acosta, J., Savigne, W., Valdez, C., Franco,N., Alba, J., Río, A. del, ... Fernández-Montequín, J.(2006). Epidermal growth factor intralesional infiltrations can prevent amputation in patients with advanced diabetic foot wounds. International Wound Journal, 3(3), 130-160.
Berlanga-Acosta, J., Mendoza-Mari, Y., Martínez, M., Valdés-Perez, C., Ojalvo, A. & Armstrong, D. (2012). Expression of cell proliferation cycle negative regulators in fibroblasts of an ischemic diabetic foot ulcer. A clinical case report. International Wound Journal, 232-236.
Berlanga-Acosta, J., Armstrong, D. G., Schultz, G. & Herrera-Martínez, L. (2014). Chronic Wounds with Emphasis in Diabetic Foot Ulcers. BioMed Research International.
Berlanga-Acosta, J., Schultz, G., López-Mola, E., Guillen-Nieto, G., García-Siverio, M. & Herrera-Martínez, L. (2013). Glucose toxic effects on granulation tissue productive cells: the diabetics’ impaired healing. Bio-Med Research International.
Centers for Disease Control and Prevention (2024, 15 de mayo). Diabetes Basics. https://www.cdc.gov/diabetes/about/index.html
Centers for Disease Control and Prevention (2024, 15 de mayo). National Diabetes Statistics Report. https://www.cdc.gov/diabetes/php/data-research/
Chen, M., Chang, C., Levian, B., Woodley, D. & Li, W. (2023). Why Are There So Few FDA-Approved Therapeutics for Wound Healing? International Journal of Molecular Science, 24. https://doi.org/10.3390/ijms242015109
Cohen, I. K., Crossland, M. C., Garrett, A. & Diegelmann, R. F. (1995). Topical Application of Epidermal Growth Factor onto Partial-Thickness Wounds in Human Volunteers Does Not Enhance Reepithelialization. Plastic and Reconstructive Surgery, 96(2), 251-254.
Cross, S. E. & Roberts, M. S. (1999). Defining a Model to Predict the Distribution of Topically Applied Growth Factors and Other Solutes in Excisional Full-Thickness Wounds. Journal of Investigative Dermatology, 112(1), 36-41.
García Ojalvo, A., Berlanga Acosta, J., Mendoza Marí, Y., Fernández Mayola, M., Valdés Pérez, C., Savigne Gutiérrez , W., .. Armstrong, D. (2017). Healing enhancement of diabetic wounds by locally infiltrated epidermal growth factor is associated with systemic oxidative stress reduction. International Wound Journal, 3, 214-225.
González Gómez, T. (2023). Oportunidades para avanzar hacia el mejoramiento de las relaciones bilaterales entre Cuba y los Estados Unidos a través del sector biofarmacéutico, a partir de la pandemia covid-19. [Trabajo de Diploma en Relaciones Internacionales. ISRI, La Habana].
Granma (2018, 21 de marzo). U.S. and Cuban companies reach agreement on Heberprot-p. https://en. granma.cu/cuba/2018-03-21/us-and-cuban-companies-reach-agreement-on-heberprot-p
Lenzer, J. (2016, 21 de marzo). US researchers blocked from testing Cuban drug. BMJ. 10.1136/bmj.i1642
McLaughlin, P. J., Cain, J., Titunick, M., Sassani, J. & Zagon, I. (2017). Topical Naltrexone Is a Safe and Effective Alternative to Standard Treatment of Diabetic Wounds. Advances in Wound Care. https://doi.org/ 10.1089/wound.2016.0725
MINSAP-HHS (2016, 13 de junio). Memorando de Entendimiento entre el Departamento de Salud y Servicios Humanos de los Estados Unidos en materia de salud y el Ministerio de Salud Pública de la República de Cuba. https://www.hhs.gov/sites/default/files/hhs-minsap-mou.pdf
Murray, M. (2006, 11 de enero). Cubans developing therapy for diabetic ulcers. NBC News. https://www.nbcnews.com/id/wbna10777359
Organización Mundial de la Salud (2023, 5 de abril). Diabetes. https://www.who.int/es/news-room/factsheets/detail/diabetes
Parker, E., Lin, J., Mahoney, T., Ume, N., Yang, G., Gabbay, R., ... Bannuru, R. (2024, enero). Economic Costs of Diabetes in the U.S. in 2022. Diabetes Care, 47(1). https://doi.org/10.2337/dci23-0085
Ruiz-McGill, R. (2016, 2 de marzo). UA Health Sciences Researchers Look to Collaborate With Cuba on Diabetic Wound Therapy. https://deptmedicine.arizona.edu/news/2016/ua-health-sciences-researchers-lookcollaborate-cuba-diabetic-wound-therapy
Sullivan, P. B.; Brueton, M. J; Tabara, Z. B.; Goodlad, R. A.; Lee, C. Y. & Wright, N. A. (1991, July 6). Epidermal growth factor in necrotising enteritis. Lancet, 338(8758), 53-54. https://doi.org/10.1016/0140-6736(91)
Whitefield, M. (2018, 1 de enero). Cuba exports medicine to dozens of countries. It would like the U.S. to be one of them. Miami Herald. https://www.miamiherald.com/news/nation-world/world/americas/cuba/article189830809.html
Zelen, C. (2024, 30 de abril). DTC Receives FDA SMP Letter for Phase 3 Clinical Trial of rhEGF. https://discothera.com/news/f/dtc-receives-fda-smp-letter-for-phase-3-clinical-trial-of-rhegf